A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

This study has been completed.

Study NCT00050843 Information provided by Celgene Corporation

First Received: December 23, 2002 Last Updated: June 23, 2005 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	February 2004
Estimated Primary Completion Date:	No date given